The diverse functions of GAPDH: views from different subcellular compartments

C Tristan, N Shahani, TW Sedlak, A Sawa - Cellular signalling, 2011 - Elsevier
Multiple roles for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) have been recently
appreciated. In addition to the cytoplasm where the majority of GAPDH is located under the …

Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis

…, MD Kornberg, MB Cascio, BI Bae, N Shahani… - Nature cell …, 2008 - nature.com
Besides its role in glycolysis, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) initiates
a cell death cascade 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 . Diverse apoptotic stimuli activate inducible …

[HTML][HTML] Tau alteration and neuronal degeneration in tauopathies: mechanisms and models

R Brandt, M Hundelt, N Shahani - … Acta (BBA)-Molecular Basis of Disease, 2005 - Elsevier
Tau becomes characteristically altered both functionally and structurally in several
neurodegenerative diseases now collectively called tauopathies. Although increasing evidence …

Functions and malfunctions of the tau proteins

N Shahani, R Brandt - Cellular and Molecular Life Sciences CMLS, 2002 - Springer
The tau proteins belong to the family of microtubule-associated proteins. They are mainly
expressed in neurons where they play major regulatory roles in the organization and integrity …

[HTML][HTML] Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease

…, PP Karunadharma, J Blin, N Shahani… - Nature …, 2021 - nature.com
The polyglutamine expansion of huntingtin (mHTT) causes Huntington disease (HD) and
neurodegeneration, but the mechanisms remain unclear. Here, we found that mHtt promotes …

[HTML][HTML] Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy

RG Mealer, AJ Murray, N Shahani… - Journal of Biological …, 2014 - ASBMB
The protein mutated in Huntington disease (HD), mutant huntingtin (mHtt), is expressed
throughout the brain and body. However, the pathology of HD is characterized by early and …

Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA–induced dyskinesia

…, RG Mealer, S Kim, F Errico, R Barrow, N Shahani… - Nature …, 2012 - nature.com
L-DOPA–induced dyskinesia, the rate-limiting side effect in the therapy of Parkinson's
disease, is mediated by activation of mammalian target of rapamycin (mTOR) signaling in the …

Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease

WM Pryor, M Biagioli, N Shahani, S Swarnkar… - Science …, 2014 - science.org
In patients with Huntington’s disease (HD), the protein huntingtin (Htt) has an expanded
polyglutamine (poly-Q) tract. HD results in early loss of medium spiny neurons in the striatum, …

Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in Huntington disease

M Sharma, S Rajendrarao, N Shahani… - Proceedings of the …, 2020 - National Acad Sciences
Huntington disease (HD) is caused by an expansion mutation of the N-terminal polyglutamine
of huntingtin (mHTT). mHTT is ubiquitously present, but it induces noticeable damage to …

Mir-592 regulates the induction and cell death-promoting activity of p75NTR in neuronal ischemic injury

…, KA Jackman, VA Padow, N Shahani… - Journal of …, 2014 - Soc Neuroscience
The neurotrophin receptor p75 NTR has been implicated in mediating neuronal apoptosis
after injury to the CNS. Despite its frequent induction in pathologic states, there is limited …